Table 1 Overall results
|  | Up to 2019 [8] | 2019–2022 |
|---|---|---|
Total number of protocols assessed for eligibility | 216 | 84 |
Number of trials planning to use HSD | 102 (47%a) | 52 (62%a) |
Number of trials planning to use HSD as the sole data for at least one outcome | 46 (45%b) | 24 (46%b) |